Pharmacokinetics of subcutaneous methotrexate.
暂无分享,去创建一个
W. Evans | R. Murphy | F. Balis | G. Reaman | D. Poplack | C. McCully | C. McCully | K. Doherty | S. Jeffries | J. Mirro | Gregory H. Reaman | William E. Evans | Robert F. Murphy | Susan L. Jeffries
[1] W. Evans,et al. Methotrexate bioavailability after oral and intramuscular administration in children. , 1987, The Journal of pediatrics.
[2] D. Alberts,et al. Methotrexate: bioavailability and pharmacokinetics. , 1985, Cancer treatment reports.
[3] F. Balis,et al. Pharmacokinetics of oral methotrexate in children. , 1983, Cancer research.
[4] G D Knott,et al. Mlab--a mathematical modeling tool. , 1979, Computer programs in biomedicine.
[5] D. R. Clark,et al. Enzymatic assay for methotrexate in serum and cerebrospinal fluid. , 1976, Clinical chemistry.
[6] P. Engstrom,et al. Comparison of serum concentrations of methotrexate after various routes of administration , 1975, Cancer.
[7] E. Henderson,et al. The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man. , 1965, Cancer research.
[8] J. Mcvie,et al. Bioavailability of methotrexate: Implications for clinical use , 2004, Cancer Chemotherapy and Pharmacology.
[9] C. R. Pinkerton,et al. Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia , 2004, Cancer Chemotherapy and Pharmacology.
[10] A. Preece,et al. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia , 2004, Cancer Chemotherapy and Pharmacology.